![]() Methods: MEDLINE, Web of Science, and EMBASE were searched 5 th of August 2022 and updated on the 25 th of April 2023 to identify studies that assess qualitative olfactory dysfunction in COVID-19 patients. Additionally, the formulations of symptoms are inconsistent and often unclear, and consensus around the wording of questions and responses is needed.Īim of study: The aim of this systematic review is to provide an overview of tools used to assess qualitative olfactory dysfunction after COVID-19, in addition to addressing the content validity (i.e., item and response formulations) of these tools. This could have an impact on the diagnosis and treatment offered to patients. 4The Norwegian School of Hotel Management, Faculty of Social Sciences, University of Stavanger, Stavanger, Norwayīackground: There is a lack of overview of the tools used to assess qualitative olfactory dysfunction, including parosmia and phantosmia, following COVID-19 illness.3The Cognitive and Behavioral Neuroscience Lab, University of Stavanger, Stavanger, Norway.2SHARE–Centre for Resilience in Healthcare, Faculty of Health Sciences, University of Stavanger, Stavanger, Norway. ![]() ![]() 1Department of Quality and Health Technology, Faculty of Health Sciences, University of Stavanger, Stavanger, Norway.Annelin Espetvedt 1,2,3 *, Siri Wiig 1,2, Kai Victor Myrnes-Hansen 1,4 and Kolbjørn Kallesten Brønnick 1,3 ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |